NCT05169762 Feminizing Treatment in Transgender Women and Non-binary Persons
| NCT ID | NCT05169762 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Odense University Hospital |
| Condition | Transgenderism |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-02-01 |
| Primary Completion | 2035-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-02-01 with a primary completion date of 2035-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.
Eligibility Criteria
Inclusion Criteria: * assigned male at birth and eligeble for gender affirming feminizing treatment Exclusion Criteria: none \-
Contact & Investigator
Dorte Glintborg
PRINCIPAL INVESTIGATOR
Odense University Hospital
Frequently Asked Questions
Who can join the NCT05169762 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Transgenderism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05169762 currently recruiting?
Yes, NCT05169762 is actively recruiting participants. Contact the research team at dorte.glintborg@rsyd.dk for enrollment information.
Where is the NCT05169762 trial being conducted?
This trial is being conducted at Odense, Denmark.
Who is sponsoring the NCT05169762 clinical trial?
NCT05169762 is sponsored by Odense University Hospital. The principal investigator is Dorte Glintborg at Odense University Hospital. The trial plans to enroll 100 participants.